Contact
🔒 Contacts are masked. Get full emails & phones. Unlock via export ↗
Category & trade
Primary
biotech-and-biomedical-industry · embed-ft 0.47
Tree path
Business and Finance › Industries › Biotech and Biomedical Industry
Group (tier-1)
Tech stack
AI readiness
AI-Readiness score
48 / 100 · partial · see similar
AI training policy
allowed
AI-bot protection
AI files
Compliance (GEO / GDPR)
TLD
Overview
Title
Alevian | Stroke Therapeutics & Neuroregeneration
Description
Alevian is a preclinical-stage biotech developing ALE-001, a GDF11-based regenerative therapeutic for acute ischemic stroke with a 72-hour treatment window. Targeting a $14B US market with no approved therapies. Harvard-backed science, advancing toward Phase I clinical trials. Series A fundraising.
Final URL
Language
en (html)
Scanned at
2026-07-14 22:39:45